The Community Patent: What This Means for the Pharmaceutical Industry

ISSN： 1175-9046

Source： Pharmaceutical Development and Regulation, Vol.1, Iss.1, 2003-01, pp. : 3-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ITC as an attractive patent litigation forum for the biotechnology and pharmaceutical industry

By Burton Carlyn A Margonis Lisa E

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 177-180

Future Science

Access to resources Recommend Favorite

The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?

By Wndisch Karl

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 1, 2005-01 ,pp. : 21-40

Haworth Press

Access to resources Recommend Favorite

Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1937-1949

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical patent litigation in Europe

By Cook T.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Developing trends in pharmaceutical patent claims

By Cook T.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 635-643

Informa Healthcare

Access to resources Recommend Favorite